vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Perion Network Ltd. (PERI). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $368.7M, roughly 1.3× Perion Network Ltd.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 2.1%, a 4.7% gap on every dollar of revenue. Over the past eight quarters, Perion Network Ltd.'s revenue compounded faster (16.4% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Perion Network Ltd. is a publicly traded advertising technology company that provides digital advertising technology solutions to advertisers, agencies, retailers, and publishers. Its core offerings are delivered through Perion One, a unified omnichannel advertising platform designed to support campaign planning, activation, optimisation, and measurement across channels and verticals including connected television (CTV), digital out-of-home (DOOH), display, video advertising, as well as retai...
MD vs PERI — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $368.7M |
| Net Profit | $33.7M | $7.7M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | 2.0% |
| Net Margin | 6.8% | 2.1% |
| Revenue YoY | -1.7% | — |
| Net Profit YoY | 10.5% | — |
| EPS (diluted) | $0.40 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | — | ||
| Q3 25 | $492.9M | $368.7M | ||
| Q2 25 | $468.8M | $266.5M | ||
| Q1 25 | $458.4M | $157.8M | ||
| Q4 24 | $502.4M | — | ||
| Q3 24 | $511.2M | $508.9M | ||
| Q2 24 | $504.3M | $323.6M | ||
| Q1 24 | $495.1M | $145.2M |
| Q4 25 | $33.7M | — | ||
| Q3 25 | $71.7M | $7.7M | ||
| Q2 25 | $39.3M | $5.6M | ||
| Q1 25 | $20.7M | $11.8M | ||
| Q4 24 | $30.5M | — | ||
| Q3 24 | $19.4M | $78.0M | ||
| Q2 24 | $-153.0M | $45.2M | ||
| Q1 24 | $4.0M | $23.8M |
| Q4 25 | 9.9% | — | ||
| Q3 25 | 13.8% | 2.0% | ||
| Q2 25 | 12.8% | -1.7% | ||
| Q1 25 | 7.0% | 5.4% | ||
| Q4 24 | 7.8% | — | ||
| Q3 24 | 6.6% | 15.1% | ||
| Q2 24 | -31.3% | 13.7% | ||
| Q1 24 | 3.2% | 16.9% |
| Q4 25 | 6.8% | — | ||
| Q3 25 | 14.5% | 2.1% | ||
| Q2 25 | 8.4% | 2.1% | ||
| Q1 25 | 4.5% | 7.5% | ||
| Q4 24 | 6.1% | — | ||
| Q3 24 | 3.8% | 15.3% | ||
| Q2 24 | -30.3% | 14.0% | ||
| Q1 24 | 0.8% | 16.4% |
| Q4 25 | $0.40 | — | ||
| Q3 25 | $0.84 | — | ||
| Q2 25 | $0.46 | — | ||
| Q1 25 | $0.24 | — | ||
| Q4 24 | $0.37 | — | ||
| Q3 24 | $0.23 | — | ||
| Q2 24 | $-1.84 | — | ||
| Q1 24 | $0.05 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $156.2M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $722.9M |
| Total Assets | $2.2B | $915.5M |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | — | ||
| Q3 25 | $340.1M | $156.2M | ||
| Q2 25 | $224.7M | $156.2M | ||
| Q1 25 | $99.0M | $156.2M | ||
| Q4 24 | $229.9M | — | ||
| Q3 24 | $103.8M | $187.6M | ||
| Q2 24 | $19.4M | $187.6M | ||
| Q1 24 | $8.0M | $187.6M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | — | ||
| Q3 25 | $890.7M | $722.9M | ||
| Q2 25 | $833.8M | $722.9M | ||
| Q1 25 | $789.2M | $722.9M | ||
| Q4 24 | $764.9M | — | ||
| Q3 24 | $732.5M | $718.1M | ||
| Q2 24 | $706.5M | $718.1M | ||
| Q1 24 | $856.2M | $718.1M |
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.2B | $915.5M | ||
| Q2 25 | $2.1B | $915.5M | ||
| Q1 25 | $2.0B | $915.5M | ||
| Q4 24 | $2.2B | — | ||
| Q3 24 | $2.1B | $1.1B | ||
| Q2 24 | $2.0B | $1.1B | ||
| Q1 24 | $2.2B | $1.1B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $2.6M |
| Free Cash FlowOCF − Capex | — | $-2.9M |
| FCF MarginFCF / Revenue | — | -0.8% |
| Capex IntensityCapex / Revenue | — | 1.5% |
| Cash ConversionOCF / Net Profit | 3.39× | 0.34× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | — | ||
| Q3 25 | $137.3M | $2.6M | ||
| Q2 25 | $137.2M | — | ||
| Q1 25 | $-117.5M | — | ||
| Q4 24 | $133.0M | — | ||
| Q3 24 | $91.8M | $105.2M | ||
| Q2 24 | $107.0M | — | ||
| Q1 24 | $-125.2M | $17.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-2.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $104.7M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $17.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | -0.8% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 20.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 12.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.1% |
| Q4 25 | 3.39× | — | ||
| Q3 25 | 1.91× | 0.34× | ||
| Q2 25 | 3.49× | — | ||
| Q1 25 | -5.66× | — | ||
| Q4 24 | 4.36× | — | ||
| Q3 24 | 4.72× | 1.35× | ||
| Q2 24 | — | — | ||
| Q1 24 | -31.03× | 0.75× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
PERI
| Advertising Solutions | $231.4M | 63% |
| Search Advertising | $137.3M | 37% |
